Table 3.
Case nos. | Site | Age (years), sex | Stage (metastatic sites) | Prior therapy | No. of cycles | EFS (months) | OS (months) |
---|---|---|---|---|---|---|---|
9 | Cleveland | 65, M | T4N0M1 (lung) | Surgery | 19 | 20 | 37.9 |
18 | Detroit | 60, F | T4NxM1 (lung) | Surgery + dox + XRT | 8.67 | 8.8 | 24.4+ |
21 | Cleveland | 53, F | T4N0M1 (lung) | Surgery | 4 | 3.1 | 15.9 |
M, male; F, female; dox, doxorubicin; XRT, radiation; EFS, event-free survival; OS, overall survival.